The Securities and Exchange Commission and Federal Trade Commission are investigating Abbott Laboratories’ baby-formula enterprise, the corporate stated.
The SEC’s enforcement division despatched a subpoena to Abbott
ABT,
in December requesting details about its powder infant-formula enterprise and associated public disclosures, the corporate stated Friday in a securities submitting.
Source web site: www.marketwatch.com
